// App-Quantinova.ai

: Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

Researchers

Presenter

  • Igor Stojkov

Principal Investigators

  • Annette Conrads-Frank

  • Ursula Rochau

  • Karin A Koinig

  • Helena Borba

  • Marjan Arvandi

  • Pierre Fenaux

  • Argiris Symeonidis

  • David Bowen

  • Moshe Mittelman

  • Corine van Marrewijk

  • Theo de Witte

  • Fabio Efficace

  • Uwe Siebert

  • Reinhard Stauder

Medical Centers

  • Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology,Hall in Tirol,Austria

  • Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology,Hall in Tirol,Austria

  • Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University (IMU), Innsbruck, Innsbruck, Austria

  • Department of Pharmacy, Pharmaceutical Sciences Postgraduate Research Program, Federal University of Parana, Curitiba, Brazil

  • Service d'Hématologie,Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Hôpital Saint-Louis / Université Paris 7, Paris, France

  • Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece

  • St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom

  • Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty,Tel Aviv University,Tel Aviv,Israel

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Dep. of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, Netherlands

  • Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy

  • UMIT, Dept. of Public Health, Health Services Research & HTA / Harvard Univ., Dept. Health Policy & Management, Institute for Technology Assessment, Hall i. T. (Austria) /, Boston, MA

Locations

  • Austria

  • Brazil

  • France

  • Greece

  • United Kingdom

  • Israel

  • Netherlands

  • Italy

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved